Genesis to Join International Swaps and Derivatives Association
3.5.2022 16:00:00 EEST | Business Wire | Press release
Genesis, a digital asset industry pioneer and the premier institutional crypto derivatives provider, today announced that GGC International Limited has joined the International Swaps and Derivatives Association (ISDA) as a Primary Member.
Genesis, through its GGC International Limited entity, was one of the first participants in the crypto derivatives market and enters into over-the-counter derivatives referencing a broad range of digital asset underliers. Its expert team of trading professionals facilitates transactions for both crypto-natives and traditional financial market participants who want to enter this unique market. As a member of ISDA, Genesis will continue to help shape the direction of the digital asset derivatives markets towards making them safe and efficient for all participants.
"Genesis is a pioneer in crypto liquidity, in spot OTC, lending, and bilateral OTC derivatives,” said Josh Lim, Head of Derivatives at Genesis. “As one of the earliest dealing desks to provide options liquidity to crypto-native hedge funds and corporates in the space, we've helped to shape much of the existing set of documentation that has become embedded into derivatives relationships throughout the industry. We look forward to working with our fellow ISDA members as this market continues to mature.”
About Genesis
Genesis is a full-service digital currency prime brokerage, providing a single point of access for the digital currency needs of global institutional investors. Genesis combines unrivaled operational excellence, a seamless user experience, and best-in-class client service to provide the full suite of services global investors require to manage their digital asset portfolios.
The firm offers sophisticated market participants a fully integrated platform to trade, borrow, lend, and custody digital assets, creating new opportunities for leverage and yield while increasing capital efficiency and security for counterparties.
Genesis is a subsidiary of Digital Currency Group (DCG), one of the largest private investors in blockchain and digital asset companies.
For more information on Genesis, please visit genesistrading.com and follow @GenesisTrading on Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220503005231/en/
Contact information
Marc Yaklofsky
press@genesistrading.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Modon's Hudayriyat Golf Estates Sets UAE Record With More Than AED 13 Billion in Sales Within Days of Launch7.7.2026 21:36:00 EEST | Press release
Modon has set a new benchmark for the UAE real estate market with the launch of Hudayriyat Golf Estates on Hudayriyat Island, Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707126559/en/ Modon's Hudayriyat Golf Estates sets UAE record with more than AED 13 billion in sales within days of launch (Photo: AETOSWire) Within days of launch, the community achieved record-breaking sales exceeding AED 13 billion, marking the highest publicly recorded sales value for a single residential project launch in the UAE. Comprising an exclusive collection of golf mansions, villas, and townhouses, the development saw 1,700 of its residences sold after few days of launch. The response from buyers and investors reflects confidence in Abu Dhabi’s real estate market and Modon’s development vision, while reinforcing Hudayriyat Island’s position as a premier lifestyle destination. Designed around privacy, wellbeing and premium living
Loomis Sayles Growth Equity Strategies Team Celebrates Twenty-Year Milestones7.7.2026 17:36:00 EEST | Press release
Loomis, Sayles & Company, the century-old investment manager with nearly $418 billion in assets under management, proudly celebrates the 20-year anniversaries of the Loomis Sayles Large Cap Growth and the Loomis Sayles All Cap Growth strategies, as well as a differentiated approach to growth equity investing under the leadership of Aziz V. Hamzaogullari, CFA, the founder, chief investment officer and portfolio manager of the Loomis Sayles Growth Equity Strategies (GES) Team. Aziz is also an executive vice president and a member of the firm’s Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707992418/en/ Celebrating 20 Years of The Power of Active Management Done Right GES is a cohesive team with 20 years of alpha generation and a long-term, private equity approach to investing. Under Aziz Hamzaogullari’s leadership since 2010, assets under management for GES have grown from $1.9 billion to $98.2 billion
Integral Ad Science Appoints Lidiane Jones Chief Executive Officer7.7.2026 16:35:00 EEST | Press release
Integral Ad Science (IAS), one of the world's most trusted media quality companies, today announced the appointment of Lidiane Jones as Chief Executive Officer, effective immediately. Jones succeeds Lisa Utzschneider, who led IAS for more than seven years and will remain with the company as Special Advisor to the Board through the end of 2026 to support a seamless transition. Utzschneider will also serve as a Special Advisor to Novacap and their portfolio companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707780892/en/ Lidiane Jones: Integral Ad Science CEO, Photo Credit: Pamela Hanson The appointment reflects IAS's long-term strategic vision for the future of digital advertising. As AI transforms how media is planned, bought, measured, and optimized, advertisers increasingly need trusted intelligence to make real-time decisions. Jones's deep expertise across product, technology, and AI uniquely positions IAS to bu
Andersen Global Adds Collaborating Firm Abcoo Law Firm7.7.2026 16:30:00 EEST | Press release
Andersen Global strengthens its presence in Türkiye with collaborating firm Abcoo Law Firm, enhancing the organization’s existing platform in the country with the addition of legal capabilities. Founded in 2014, Abcoo advises local and international clients across a broad range of legal services, with experience in corporate and M&A, real estate and construction, dispute resolution, employment, compliance, banking and finance, competition and intellectual property law. The firm is consistently recognized as a top tier and leading firm by international publications, including The Legal 500. Abcoo supports organizations across a wide range of industries, including real estate and construction, retail, textile, cosmetics, automotive, logistics, chemicals, IT, energy, healthcare, manufacturing and financial services, providing strategic legal guidance and commercially focused solutions. “Our focus has always been on understanding each client’s objectives and providing practical, commercial
Altasciences and Evidence Matters Advance AI-Driven Drug Development With Nonclinical Automation Breakthrough7.7.2026 16:00:00 EEST | Press release
Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) of RegulatoryFlow (“RegFlow”), following the announcement of the companies’ strategic collaboration in August 2025. The POC demonstrated the extension of AI-driven efficiencies from clinical reporting into nonclinical workflows, marking a significant step forward in accelerating drug development timelines. Building on proven results in clinical reporting, where the collaboration has achieved up to first-draft clinical study reports (CSRs), the teams have now successfully applied similar AI capabilities to nonclinical data through high-quality parsing of raw and SEND datasets in a proof-of-concept. This advancement aligns with the Altasciences Acceleration Platform, designed to fast-track drug development across the early-phase development continuum. “This milestone reflects the power of in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom